Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,858 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Suryavanshi N, Murrill M, Gupta A, Hughes M, Hesseling A, Kim S, Naini L, Jones L, Smith B, Gupte N, Dawson R, Mave V, Meshram S, Mendoza-Ticona A, Sanchez J, Kumarasamy N, Comins K, Conradie F, Shenje J, Nerette Fontain S, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo U, Cristina Garcia Ferreira A, Okeyo E, Swindells S, Churchyard G, Shah NS. Suryavanshi N, et al. Among authors: hughes m. Clin Infect Dis. 2020 Jan 16;70(3):436-445. doi: 10.1093/cid/ciz254. Clin Infect Dis. 2020. PMID: 30919881 Free PMC article.
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.
McMahon DK, Zheng L, Hitti J, Chan ES, Halvas EK, Hong F, Kabanda J, Taulo F, Kumarasamy N, Bonhomme J, Wallis CL, Klingman KL, Hughes MD, Mellors JW. McMahon DK, et al. Clin Infect Dis. 2013 Apr;56(7):1044-51. doi: 10.1093/cid/cis1219. Epub 2013 Jan 8. Clin Infect Dis. 2013. PMID: 23300238 Free PMC article. Clinical Trial.
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.
Périssé AR, Smeaton L, Chen Y, La Rosa A, Walawander A, Nair A, Grinsztejn B, Santos B, Kanyama C, Hakim J, Nyirenda M, Kumarasamy N, Lalloo UG, Flanigan T, Campbell TB, Hughes MD; P E A R L S study team of the ACTG. Périssé AR, et al. Among authors: hughes md. PLoS One. 2013 Dec 31;8(12):e83643. doi: 10.1371/journal.pone.0083643. eCollection 2013. PLoS One. 2013. PMID: 24391801 Free PMC article. Clinical Trial.
A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.
Erlandson KM, Taejaroenkul S, Smeaton L, Gupta A, Singini IL, Lama JR, Mngqibisa R, Firnhaber C, Cardoso SW, Kanyama C, Machado da Silva AL, Hakim JG, Kumarasamy N, Campbell TB, Hughes MD. Erlandson KM, et al. Among authors: hughes md. Open Forum Infect Dis. 2015 Jun 24;2(3):ofv095. doi: 10.1093/ofid/ofv095. eCollection 2015 Sep. Open Forum Infect Dis. 2015. PMID: 26213694 Free PMC article.
Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.
Singini I, Campbell TB, Smeaton LM, Kumarasamy N, La Rosa A, Taejareonkul S, Safren SA, Flanigan TP, Hakim JG, Hughes MD; ACTG A5175/PEARLS Study Team.. Singini I, et al. Among authors: hughes md. HIV Clin Trials. 2016;17(5):173-180. doi: 10.1080/15284336.2016.1201300. Epub 2016 Jul 29. HIV Clin Trials. 2016. PMID: 27472067 Free PMC article.
Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women.
Torres TS, Harrison LJ, La Rosa AM, Cardoso SW, Zheng L, Ngongondo M, Some F, Lalloo UG, Mwelase T, Collier AC, Hughes MD; AIDS Clinical Trials Group (ACTG) A5273 Study Group. Torres TS, et al. Among authors: hughes md. AIDS. 2018 Mar 13;32(5):583-593. doi: 10.1097/QAD.0000000000001738. AIDS. 2018. PMID: 29334547 Free PMC article. Clinical Trial.
Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
Ngongondo M, Miyahara S, Hughes MD, Sun X, Bisson GP, Gupta A, Kumwenda J, Lavenberg JA, Torres TS, Nyirenda M, Kidonge KK, Hosseinipour MC; AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Ngongondo M, et al. Among authors: hughes md. J Acquir Immune Defic Syndr. 2018 May 1;78(1):54-61. doi: 10.1097/QAI.0000000000001641. J Acquir Immune Defic Syndr. 2018. PMID: 29406428 Free PMC article. Clinical Trial.
3,858 results